Orna Therapeutics

Orna Therapeutics is a biotechnology company dedicated to developing a new class of circular RNA medicines, called oRNA®, which they believe have significant advantages over traditional linear mRNA therapies. Their platform combines novel technology to design circular RNA transcripts that drive protein expression with validated and unique delivery solutions, primarily focused on oncology and autoimmune diseases. Their oRNA® platform offers several advantages, including simplified production, improved formulatability, longer RNA half-life, and increased protein expression, making it a highly disruptive, new class of RNA therapeutics.

Orna has developed two key delivery platforms: panCAR™ targets multiple lineages of the immune system at once, and SiTu Editing in the Marrow (STEM)™, which targets stem cells in the bone marrow. Both platforms are designed to be simple, scalable, and reach parts of the body other than the liver, a significant advantage over current RNA delivery technologies. Orna is rapidly advancing their pipeline, with a focus on developing best-in-class panCAR in vivo CAR RNA therapies and expanding existing gene editing delivery solutions with circular RNA to address unmet needs in multiple diseases.

Orna Therapeutics provides a comprehensive and competitive benefits package that aims to support both employees and their dependents. Their benefits include health coverage, a 401(k) matching program, paid time off, and various lifestyle, wellness, and mental health resources. The specific details of their benefits package for the 2023 plan year can be viewed on their website, though further specifics are not provided.

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of circular RNA medicines, called oRNA®, to treat various diseases. They are focused on leveraging their unique oRNA® platform and LNP delivery technologies to develop innovative therapies that address limitations of traditional linear mRNA therapeutics. Their vision is to provide first-in-class RNA drugs that target specific areas of the body, such as oncology, autoimmune diseases, infectious diseases, and even certain genetic diseases.

Orna Therapeutics fosters a culture of innovation, collaboration, and growth, prioritizing its employees' well-being and encouraging them to think outside the box. The company encourages a team-oriented environment where individuals can openly share their ideas and perspectives, and its values emphasize the importance of inclusivity, hard work, and a positive work-life balance. Orna strives to create a fun and engaging workplace where its employees, dubbed "Ornacorns," feel valued and supported in achieving their full potential.

Orna Therapeutics believes in the power of belonging and is committed to building a diverse and inclusive team that reflects the world's diversity. They strive to create a culture where all employees feel safe, included, and heard, allowing them to bring their whole selves to work and reach their full potential.